Possessing recognized the palmitoylation motif of APLNR, we designed a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation internet site in combination with morphine, can inhibit the event of NCP, like pain incidence, microglial activation, and inflammatory component https://annieb890vhr8.onzeblog.com/profile